The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)May 11, 2026 — Pershing Square USA (NYSE: PSUS) and Pershing Square Inc. (NYSE: PS) announced the closing of their combined initial public offerings and previously announced combined private placement, generating gross proceeds of $5 billion for PSUS before deducting sales loads, placement fees and offering expenses.
May 11, 2026 — Delta Gold Technologies (Aquis: DGQ /OTC:DGQTF) is featured in the debut episode of The Innovation Report Series, a new documentary initiative exploring technologies, industries and companies shaping the future global economy. The first episode, The Quantum Revolution, examines the advancing commercial potential of quantum technologies and their potential impact across industries, while the broader series explores the intersection of innovation, capital markets and industrial transformation.
May 11, 2026 — This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.
May 11, 2026 — This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.
May 11, 2026 — This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.
May 11, 2026 — Twin Vee PowerCats (NASDAQ: VEEE)reported first-quarter 2026 revenue growth of approximately 10% year over year and 31% sequentially, marking its fourth consecutive quarter of year-over-year revenue gains, as the company continued expanding its product lineup with the relaunch of Bahama Boat Works. Twin Vee posted a net loss of $2.
May 11, 2026 — Datavault AI (NASDAQ: DVLT) highlighted the strategic positioning of its distributed edge computing network ahead of this week’s anticipated U. S.
May 11, 2026 — Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement.
May 11, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
May 11, 2026 — HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG patch in approximately 50 patients with suspected coronary artery disease at two hospitals in Belgrade, Serbia. The study will compare synthesized 12-lead ECG readings generated by the company’s patch immediately following exercise stress testing against standard 12-lead ECGs, supporting HeartBeam’s regulatory strategy for a device designed to expand ambulatory cardiac monitoring beyond rhythm assessment into ischemia detection within an established approximately $2 billion patch-based monitoring market.
May 11, 2026 — The GMP Bio joint venture contributed a $249 million increase to Oncotelic’s balance sheet through independent third-party valuation The company is leveraging a deep intellectual property portfolio, including more than 500 patent applications and 75 issued patents Oncotelic’s PDAOAI platform has integrated approximately 28 million scientific abstracts and is advancing toward commercial deployment with robotics integration In clinical-stage biotechnology, the central challenge is rarely scientific discovery. It is capital.
May 11, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
May 11, 2026 — This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.
May 11, 2026 — This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.
May 11, 2026 — BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (“T2DM”) have become two of the most pressing healthcare challenges worldwide, driving rising rates of cardiovascular disease, fatty liver disease, kidney complications and escalating healthcare costs. What began as a niche class of diabetes medications has evolved into one of the most transformative therapeutic categories in modern medicine, with GLP-1 receptor agonists now reshaping obesity treatment, metabolic care and potentially even neurodegenerative disease management.
May 11, 2026 — BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this challenge is the blood-brain barrier (BBB), a biological defense system that prevents most therapeutics from reaching the central nervous system (“CNS”).
May 11, 2026 — AINewsWire Editorial Coverage: The nature of modern warfare is being rewritten in real time, driven by the rapid rise of cheap, mass-produced drones that are reshaping the economics of conflict. In war zones such as Ukraine, millions of low-cost systems, often built in small workshops or adapted from commercial designs, are now performing missions once reserved for advanced aircraft and precision-guided weapons.
May 11, 2026 — BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to healthcare and public health management. Traditional methods such as breathalyzers, blood tests and urine screenings are often limited by their invasiveness, delayed results or inability to assess real-time impairment, particularly in cases involving multiple substances.
May 11, 2026 — The copper market has remained on edge as geopolitical risks stoke volatility. As a result, prices have swung widely in response to news headlines.
May 11, 2026 — Apple has agreed to pay a $250 million settlement in the United States to resolve a lawsuit over its artificial intelligence marketing for recent iPhones. The case focused on claims that the company misled customers about the capabilities and availability of new AI features promoted under the name Apple Intelligence.